TELIX PHARMACEUTICALS LTD(TLX.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

TLX.AU TELIX PHARMACEUTICALS LTD

Not Yet Opened 05-23 16:12:00 AEST

15.59

-0.19

-1.20%

High15.64	Low15.35	Vol2.01M
Open15.62	D1 Closing15.78	Amplitude1.84%
Mkt Cap5.21B	Tradable Cap4.09B	Total Shares334.13M
T/O31.22M	T/O Rate0.76%	Tradable Shares262.40M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"TLX.AU","market":"AU","secType":"STK","nameCN":"TELIX PHARMACEUTICALS LTD","latestPrice":15.59,"timestamp":1716444720000,"preClose":15.78,"halted":0,"volume":2006435,"delay":0,"nameEN":"TELIX PHARMACEUTICALS LTD","floatShares":262396802,"shares":334126898,"eps":0.0161,"marketStatus":"Not Yet Opened","change":-0.19,"latestTime":"05-23 16:12:00 AEST","open":15.62,"high":15.64,"low":15.35,"amount":31222762,"amplitude":0.018378,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.0161,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1716508800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":15.78,"openAndCloseTimeList":[[1716422400000,1716444000000]],"volumeRatio":1.5790686083185559,"lotSize":1,"tradeCurrency":"AUD"},"requestUrl":"/m/hq/s/TLX.AU/","defaultTab":"news","newsList":[{"id":"2437924282","title":"Why Droneshield, TechnologyOne, Telix, and Webjet shares are rising today","url":"https://stock-news.laohu8.com/highlight/detail?id=2437924282","media":"MotleyFool","top":-1,"share":"https://ttm.financial/m/news/2437924282?lang=en_us&edition=fundamental","pubTime":"2024-05-22 12:39","pubTimestamp":1716352742,"startTime":"0","endTime":"0","summary":"TheS&P/ASX 200 Index(ASX: XJO) is on course to record a small gain on Wednesday. In afternoon trade, the benchmark index is up 0.1% to 7,858.8 points. Four ASX shares that are rising more than most to","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/05/22/why-droneshield-technologyone-telix-and-webjet-shares-are-rising-today/","is_publish_highlight":false,"gpt_icon":0},{"id":"2437728525","title":"Guess which 7 ASX 200 shares are smashing new 52-week highs today","url":"https://stock-news.laohu8.com/highlight/detail?id=2437728525","media":"MotleyFool","top":-1,"share":"https://ttm.financial/m/news/2437728525?lang=en_us&edition=fundamental","pubTime":"2024-05-22 11:15","pubTimestamp":1716347726,"startTime":"0","endTime":"0","summary":"Seven S&P/ASX 200 Index shares are leaping to 52-week highs today. Yep, seven!Their strong performance is helping lift the benchmark index 0.3% in early afternoon trade. Any guesses?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/05/22/guess-which-7-asx-200-shares-are-smashing-new-52-week-highs-today/","is_publish_highlight":false,"gpt_icon":0},{"id":"2437462429","title":"Market Close: ASX closes flattish as traders shrugs off new NASDAQ record","url":"https://stock-news.laohu8.com/highlight/detail?id=2437462429","media":"The Market Herald","top":-1,"share":"https://ttm.financial/m/news/2437462429?lang=en_us&edition=fundamental","pubTime":"2024-05-21 15:02","pubTimestamp":1716274920,"startTime":"0","endTime":"0","summary":"The ASX200 closed just 12 points down  as the local markets shrugged off another record close for the NASDAQ on Monday night.The IT and industrials sectors were strongest, both gaining just shy of 0.75%.Telecommunications fell the hardest, to close the session down more than 1%.In this bulletin, we’ll look at news from ALS, Sonic Healthcare, Telix Pharmaceuticals, Alara Resources, Infratil and James Hardie Industries.Assay laboratory firm ALS  jumped 5% after releasing its FY24 results and posting a 19.6c partly-franked dividend.The company’s underlying revenue was up 6.8% on the previous year, while underlying NPAT was down 1.3%. The dividend payout was slightly lower vs pcp.Meanwhile, Telix Pharmaceuticals  hung onto the day’s gains, closing just 0.13% higher after announcing its Phase I dose escalation study of drug candidate TLX592 was concluded.Finally, Alara Resources  gained 12% on news it’ll ship its first copper and gold concentrate from its joint-venture Al Wahishi Majazza pl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://themarketonline.com.au/market-close-asx-closes-flattish-as-traders-shrugs-off-new-nasdaq-record-2024-05-21/","is_publish_highlight":false,"gpt_icon":0},{"id":"2436714020","title":"Market Close: Energy and materials turn ASX green","url":"https://stock-news.laohu8.com/highlight/detail?id=2436714020","media":"The Market Herald","top":-1,"share":"https://ttm.financial/m/news/2436714020?lang=en_us&edition=fundamental","pubTime":"2024-05-20 14:41","pubTimestamp":1716187260,"startTime":"0","endTime":"0","summary":"The ASX200closed around 0.63% up with energy soaring 2.3% and materials 1.9%.The Star Entertainment Group shot up 20% onnews it’sreceived interest from a number of external partiesinterested in making atakeoverbid.Morgan Stanley and Jefferies are among firms acting as managers for the IPO process, signifying a high level of confidence fromTelixit intends toprogress theplan.Earnings before interest and tax were down 54% on theprevious corresponding period,and its underlying profit after taxdropped 72%.The company cites challenging conditions, cautious client sentiment, lower livestock prices as well ascrop inputcosts.It’s paying a 50% franked, 18-cent dividend.it shed0.86% ashealthcare giantsdragged:CSL  shed 0.7% Cochlear  was down 3%, and ResMed  lost more than 1%.Construction sector company Duratec  was down 6% after revising its guidance for revenue and normalised EBITDA for FY24.Duratec’s revenue guidance has been reduced to $550-565 million from $570-610 million due to delays in e","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://themarketonline.com.au/market-close-2-2024-05-20/","is_publish_highlight":false,"gpt_icon":0},{"id":"2436146348","title":"Market Update: ASX miners raise their glasses to toast copper","url":"https://stock-news.laohu8.com/highlight/detail?id=2436146348","media":"The Market Herald","top":-1,"share":"https://ttm.financial/m/news/2436146348?lang=en_us&edition=fundamental","pubTime":"2024-05-20 11:57","pubTimestamp":1716177420,"startTime":"0","endTime":"0","summary":"The ASX200 is up 0.65% – in line with futures’ predictions.Healthcare is down 0.4% – whilst materials is up 1.96% and energy 1.79% mid-session.The materials sector is having a strong run mid-session; Rio Tinto , Fortescue , and BHP Group  are all up around 2% as copper prices soared above US$5 a pound overnight, and iron ore prices recovered in Singapore.Telix Pharmaceuticals  is up more than 1% after announcing its intentions to list on the USA’s NASDAQ.Morgan Stanley and Jefferies are among the firms acting as managers for the IPO process, signifying a high level of confidence from Telix it intends to go forward with the plan.Agribusiness company Elders  is up around 2.5% despite posting weaker than expected half year results for the 6 months ending on March 31st.Compared to the previous corresponding period, the company’s underlying EBIT was down 54%, and its underlying profit after tax was also down 72%.The company cites challenging conditions, cautious client sentiment and softeni","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://themarketonline.com.au/market-update-asx-miners-raise-their-glasses-to-toast-copper-2024-05-20/","is_publish_highlight":false,"gpt_icon":0},{"id":"2436113402","title":"BRIEF-Telix Pharmaceuticals Files Registration Statement For Proposed Initial Public Offering In United States","url":"https://stock-news.laohu8.com/highlight/detail?id=2436113402","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2436113402?lang=en_us&edition=fundamental","pubTime":"2024-05-20 08:07","pubTimestamp":1716163651,"startTime":"0","endTime":"0","summary":"May 20 (Reuters) - Telix Pharmaceuticals Ltd   :   * FILES REGISTRATION STATEMENT FOR PROPOSED INITIAL PUBLIC OFFERING IN UNITED STATESFurther company coverage:    ((Reuters.Briefs@thomsonreuters.com;;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2436907461","title":"Telix Pharma gears up to launch US IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2436907461","media":"The Market Herald","top":-1,"share":"https://ttm.financial/m/news/2436907461?lang=en_us&edition=fundamental","pubTime":"2024-05-20 06:57","pubTimestamp":1716159420,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals  announced on Monday it has filed early-stage paperwork proposing to US regulators a listing on the American equities markets.Morgan Stanley and Jefferies are among the firms acting as managers for the IPO process, signifying a high level of confidence from Telix it intends to go forward with the plan.A US prospectus is already lined up for exclusive US release; Telix is ultimately aiming for the NASDAQ.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://themarketonline.com.au/telix-pharma-gears-up-to-launch-us-ipo-2024-05-20/","is_publish_highlight":false,"gpt_icon":0},{"id":"2436599634","title":"BRIEF-Telix Pharmaceuticals Says QTRLY Revenue Of A$175.0M, Up 75% On Q1 2023","url":"https://stock-news.laohu8.com/highlight/detail?id=2436599634","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2436599634?lang=en_us&edition=fundamental","pubTime":"2024-05-17 17:25","pubTimestamp":1715937912,"startTime":"0","endTime":"0","summary":"May 17 (Reuters) - Telix Pharmaceuticals Ltd   :   * QTRLY REVENUE OF A$175.0M, UP 75% ON Q1 2023   * Q1 OPERATING PROFIT OF A$28.5M, UP FROM A$5.6M OPERATING LOSS IN PRIOR CORRESPONDING QUARTER Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2435803538","title":"Inherited a substantial sum of money? Here's how I'd spend it (including the ASX stocks I'd buy)","url":"https://stock-news.laohu8.com/highlight/detail?id=2435803538","media":"MotleyFool","top":-1,"share":"https://ttm.financial/m/news/2435803538?lang=en_us&edition=fundamental","pubTime":"2024-05-14 09:03","pubTimestamp":1715648597,"startTime":"0","endTime":"0","summary":"Given the topic, let's try to keep this article as light-hearted as possible. Let's assume that one day, out of the blue, you get a call from a lawyer telling you that your mysterious great aunt Holga recently passed away at the ripe old age of 106. You can only remember meeting Holga once – on a family trip to Dusseldorf when you were still a toddler – but you must have made a good impression, because she decided to leave you all her worldly possessions, including a significant sum of money.Sure, you feel sad for poor old Holga, but she had a good run. And so, before long, your thoughts turn to how you should spend this sum of money. It could set you up for the future – and might even allow you to retire early!But you've never had so much money before, and it's hard to work out where to start. Should you invest it all in stocks?Should you blow it all at the casino?In this article, we take a look at some of the most prudent ways you can use your surprise cash injection. After all, it's","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/05/14/inherited-a-substantial-sum-of-money-heres-how-id-spend-it-including-the-asx-stocks-id-buy/","is_publish_highlight":false,"gpt_icon":0},{"id":"2432803221","title":"Two high-flying ASX shares: One upgraded, one downgraded","url":"https://stock-news.laohu8.com/highlight/detail?id=2432803221","media":"MotleyFool","top":-1,"share":"https://ttm.financial/m/news/2432803221?lang=en_us&edition=fundamental","pubTime":"2024-05-04 02:40","pubTimestamp":1714761600,"startTime":"0","endTime":"0","summary":"Two ASX shares that have made their shareholders smile this year are DroneShield Ltd  and Telix Pharmaceuticals Ltd . Since the start of the year, their shares have risen by approximately 120% and 50%, respectively. As a comparison, the Australian share market is up around 0.5% over the same period. However, one leading broker believes that one of these high-flying ASX shares could have peaked for the time being. This has led to its analysts downgrading its shares to a hold rating. The good news for the other share is that its analysts have gone the other way with it. Despite its very strong gains, the broker has upgraded it to a buy rating from hold this week. Which ASX shares has been downgraded?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/05/04/two-high-flying-asx-shares-one-upgraded-one-downgraded/","is_publish_highlight":false,"gpt_icon":0},{"id":"2432695404","title":"This fundie invested in Neuren at a $70m valuation. It's now $2.4 billion.","url":"https://stock-news.laohu8.com/highlight/detail?id=2432695404","media":"LiveWire","top":-1,"share":"https://ttm.financial/m/news/2432695404?lang=en_us&edition=fundamental","pubTime":"2024-05-02 09:00","pubTimestamp":1714611605,"startTime":"0","endTime":"0","summary":"The newly minted KP Rx Healthcare Opportunities Fund, managed by Hashan De Silva, comes from a strong pedigree.De Silva previously worked for Karst Peak, a spinoff from Tiger Management, run by legendary hedge fund manager Julian Robertson.Karst Peak founder Adam Leitzes is providing seed capital for KP Rx, following the playbook of Robertson, who seeded and mentored numerous ex-employees to run their own investment houses - affectionately known as \"Tiger cubs\".In addition to the seed capital from Karst Peak, KP Rx’s investors include some of Australia’s most successful healthcare entrepreneurs including Dr Chris Behrenbruch , Patrick Davies , Lou Panaccio  to name a few.The fund is not focused on GP clinics, hospitals, or healthcare services. Rather, it focuses on later-stage businesses, with De Silva describing KP Rx as a \"series A, B, or C investor, where we are coming in once a lot of the initial preclinical stuff has been done.\". Previous successful investments include now ASX-lis","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/this-fundie-invested-in-neuren-at-a-70m-valuation-it-s-now-2-4-billion","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/this-fundie-invested-in-neuren-at-a-70m-valuation-it-s-now-2-4-billion","is_publish_highlight":false,"gpt_icon":0},{"id":"2429643015","title":"Analysis of Telix Pharmaceuticals, Bank of Queensland, MAAS Group Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2429643015","media":"Informed Investor","top":-1,"share":"https://ttm.financial/m/news/2429643015?lang=en_us&edition=fundamental","pubTime":"2024-04-24 14:23","pubTimestamp":1713939783,"startTime":"0","endTime":"0","summary":"Fund Manager Chris Pedersen discusses Telix Pharmaceuticals, Bank of Queensland and MAAS Group Holdings.","market":null,"thumbnail":"https://informed-investor.s3.ap-southeast-2.amazonaws.com/images/News/59eae21f0fdaf33d285b41d0ffa8d2675fc2646e.jpg","type":0,"news_type":0,"thumbnails":["https://informed-investor.s3.ap-southeast-2.amazonaws.com/images/News/59eae21f0fdaf33d285b41d0ffa8d2675fc2646e.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.sharecafe.com.au/2024/04/24/analysis-of-telix-pharmaceuticals-bank-of-queensland-maas-group-holdings/","is_publish_highlight":false,"gpt_icon":0},{"id":"2429104434","title":"Up 74% in 6 months, guess which ASX 200 healthcare stock just hit another all-time high","url":"https://stock-news.laohu8.com/highlight/detail?id=2429104434","media":"MotleyFool","top":-1,"share":"https://ttm.financial/m/news/2429104434?lang=en_us&edition=fundamental","pubTime":"2024-04-24 14:07","pubTimestamp":1713938856,"startTime":"0","endTime":"0","summary":"One ASX healthcare stock is clocking a new record price today while the S&P/ASX 200 Index  struggles to keep its head above water.The Aussie share market is flailing this afternoon after the Australian Bureau of Statistics  published March inflation figures.To the absolute displeasure of Australian equity investors, the monthly consumer price index rose 1.0% in the March-ending quarter, reflecting an annual rate of 3.6%. Economists were expecting 3.5%. The concern of a prolonged interest rate pause is dampening much of the market today.But breaking through the bemoaning bout is an ASX healthcare stock on a roll. Factoring in today's 4% gain, this little beauty is up 73.9% in a six-month timespan.I'm talking about none other than Telix Pharmaceuticals Ltd .Why are investors buying up this ASX healthcare stock?Topping it off, the ASX healthcare stock reaffirmed guidance of US$445 million to US$465 million in revenue for FY2024.Monash Investors' Shane Fitzgerald has described this ASX hea","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/04/24/up-74-in-6-months-guess-which-asx-200-healthcare-stock-just-hit-another-all-time-high/","is_publish_highlight":false,"gpt_icon":0},{"id":"2429155171","title":"Why we believe Telix Pharmaceuticals is an attractive investment","url":"https://stock-news.laohu8.com/highlight/detail?id=2429155171","media":"LiveWire","top":-1,"share":"https://ttm.financial/m/news/2429155171?lang=en_us&edition=fundamental","pubTime":"2024-04-23 14:18","pubTimestamp":1713853110,"startTime":"0","endTime":"0","summary":"In the dynamic landscape of investing, uncovering hidden gems amidst the sea of opportunities often requires a keen eye for potential change and growth catalysts. Telix Pharmaceuticals , despite its relatively short tenure on the ASX, emerges as a beacon of promise in the realm of biotech ventures.In evaluating investment opportunities, the lack of an extensive historical record can obscure a company’s growth inflection points, which are critical to our decision-making process. In their absence, we rely on historical analogs from our investment experience to identify key performance indicators. Telix Pharmaceuticals, despite its brief history on the ASX, has demonstrated extraordinary progress by generating over $100 million in revenue in the March 2023 quarter, a remarkable leap from zero, less than twelve months ago. The rapid growth underscores the significant potential of their product offerings.Anticipated growth hinges on Telix’s entry into the radio-diagnostic markets for kidney","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/why-we-believe-telix-pharmaceuticals-is-an-attractive-investment","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/why-we-believe-telix-pharmaceuticals-is-an-attractive-investment","is_publish_highlight":false,"gpt_icon":0},{"id":"2429952474","title":"The Australian small-cap that could become the next CSL","url":"https://stock-news.laohu8.com/highlight/detail?id=2429952474","media":"LiveWire","top":-1,"share":"https://ttm.financial/m/news/2429952474?lang=en_us&edition=fundamental","pubTime":"2024-04-22 07:00","pubTimestamp":1713740405,"startTime":"0","endTime":"0","summary":"A little over six months ago, Monash Investors’ Shane Fitzgerald tipped small caps to outperform in 2024, after a lacklustre period. Since then, the ASX Small Ordinaries index has pulled ahead of the ASX 200, as high valuations in larger companies have driven a rotation by investors.The Small Ords is up 15% since October, versus 11% for the ASX 200. In Australia at least, this coincides with the national conversation shifting toward the first interest rate cuts as opposed to further hiking from the central bank.“Investors’ willingness to go down the risk curve is heightened because now that inflation is tamed, the large caps go back to being their boring old selves,” says Fitzgerald, co-founder and director of Monash Investors.“Now, we're in an environment where quality growth will do well – and you can find a lot more quality growth in the small-cap space than in large caps,” he says.In the following, Fitzgerald explains why and discusses how his team finds opportunities. He also expl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/the-australian-small-cap-that-could-become-the-next-csl","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/the-australian-small-cap-that-could-become-the-next-csl","is_publish_highlight":false,"gpt_icon":0},{"id":"2428530906","title":"Here are the top 10 ASX 200 shares today","url":"https://stock-news.laohu8.com/highlight/detail?id=2428530906","media":"MotleyFool","top":-1,"share":"https://ttm.financial/m/news/2428530906?lang=en_us&edition=fundamental","pubTime":"2024-04-18 15:00","pubTimestamp":1713423622,"startTime":"0","endTime":"0","summary":"It turned out to be a day of high relief for ASX investors, with the S&P/ASX 200 Index  finally recording a positive session after five days of falls in a row.By the close of trade, the ASX 200 had gained a decent 0.48%, which leaves the index at 7,642.1 points.This strong Thursday session for the Australian stock market comes after a contrastingly negative night up on the American markets overnight.The Dow Jones Industrial Average Index  ended up closing in the red after initially rising, notching a 0.12% loss.The Nasdaq Composite Index  fared far worse though, tanking by 1.15%.But let's return to more positive things, with a look at what the various ASX sectors were up to today.But losers we still had. The most prominent of which were healthcare shares. The S&P/ASX 200 Healthcare Index  missed out on the good mood today, slumping 0.47%.Communications stocks were also left behind. The S&P/ASX 200 Communication Services Index  ended up losing 0.25%.Consumer discretionary stocks were ma","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/04/18/here-are-the-top-10-asx-200-shares-today-394/","is_publish_highlight":false,"gpt_icon":0},{"id":"2428580434","title":"Why BHP, Challenger, Rio Tinto, and Telix shares are pushing higher today","url":"https://stock-news.laohu8.com/highlight/detail?id=2428580434","media":"MotleyFool","top":-1,"share":"https://ttm.financial/m/news/2428580434?lang=en_us&edition=fundamental","pubTime":"2024-04-18 11:47","pubTimestamp":1713412031,"startTime":"0","endTime":"0","summary":"TheS&P/ASX 200 Index (ASX: XJO) is back on form and pushing higher on Thursday. In afternoon trade, the benchmark index is up 0.6% to 7,650.2 points. Four ASX shares that are rising more than most tod","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/04/18/why-bhp-challenger-rio-tinto-and-telix-shares-are-pushing-higher-today/","is_publish_highlight":false,"gpt_icon":0},{"id":"2428301053","title":"BUZZ-Australia's Telix Pharmaceuticals hits record high on strong quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=2428301053","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2428301053?lang=en_us&edition=fundamental","pubTime":"2024-04-18 08:36","pubTimestamp":1713400574,"startTime":"0","endTime":"0","summary":"** Shares of Telix Pharmaceuticals    jump as much as 15.3% to A$13.25 to hit a record high    ** Stock emerges as top gainer on the benchmark index    ** The biopharma co reports an 18% rise in quarterly revenue on prior quarter too $114.9 mln, driven by sales of its prostate cancer imaging product Illuccix   ** Co reaffirms FY revenue between $445 mln to $465 mln    ** Shares poised to see their best day since July 21, 2022 - if current trend holds    ** Stock has risen 24.4% this year as of last close ","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2428308667","title":"ASX 200 to open higher, S&P 500 and Nasdaq fall for a fourth straight day","url":"https://stock-news.laohu8.com/highlight/detail?id=2428308667","media":"LiveWire","top":-1,"share":"https://ttm.financial/m/news/2428308667?lang=en_us&edition=fundamental","pubTime":"2024-04-18 06:51","pubTimestamp":1713394265,"startTime":"0","endTime":"0","summary":"ASX 200 futures are trading 20 points higher, up 0.26% as of 8:30 am AEST.S&P 500 sold off intraday to finish near session lows . S&P 500 finished lower, ending near worst levels despite a positive open. S&P 500 now down 3.4% in the last four sessions and marks the first four-session decline since the start of 2024. Bond yields lower across the curve after a sharp two-day run-up. Oil prices fell ~3% as a rise in US commercial inventories, weaker economic data from China and hawkish Fedspeak outweighed Middle East supply risks. Risk-off narrative continues to focus on the hawkish repricing of Fed rate-cut expectations, geopolitical fears of a wider Middle East war, unwinding of stretched positioning and sentiment indicators. South Korea policymakers increase warnings over rapidly weakening won . ASX 200 set to open higher on Thursday after a five-day losing streak. Netanyahu pushes back against Western calls for restraint and says Israel will do \"everything necessary\" to defend itself .","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/asx-200-to-open-higher-s-p-500-and-nasdaq-fall-for-a-fourth-straight-day","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/asx-200-to-open-higher-s-p-500-and-nasdaq-fall-for-a-fourth-straight-day","is_publish_highlight":false,"gpt_icon":0},{"id":"2428679343","title":"BRIEF-Telix Pharmaceuticals Posts Q1 Unaudited Total Revenue Of $114 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2428679343","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2428679343?lang=en_us&edition=fundamental","pubTime":"2024-04-17 15:41","pubTimestamp":1713339685,"startTime":"0","endTime":"0","summary":"April 17 (Reuters) - Telix Pharmaceuticals Ltd   :   * Q1 UNAUDITED TOTAL REVENUE OF US$114 MILLION, UP 18% QOQ   * REAFFIRMS GUIDANCE FOR FULL YEAR REVENUE EXPECTED TO BE IN RANGE OF $445M TO $465MFurther company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://telixpharma.com","stockEarnings":[{"period":"1week","weight":0.0091},{"period":"1month","weight":0.0902},{"period":"3month","weight":0.4819},{"period":"6month","weight":0.6638},{"period":"1year","weight":0.3557},{"period":"ytd","weight":0.5466}],"compareEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0.045},{"period":"3month","weight":0.0991},{"period":"6month","weight":0.1401},{"period":"1year","weight":0.1451},{"period":"ytd","weight":0.1257}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Telix Pharmaceuticals Limited, an oncology company, develops molecularly targeted radiation products for unmet needs in cancer care in Australia. Its lead products include TLX250, which is in Phase II clinical trials for the diagnosis and treatment of renal (kidney) cancer; TLX250-CDx that is in Phase III clinical trials for the diagnosis and treatment of renal (kidney) cancer; TLX591, which is in pre-Phase 3 development for the diagnosis and treatment of metastatic castrate-resistant prostate cancer; TLX591-CDx that is in Phase III clinical trials for the diagnosis and treatment of metastatic castrate-resistant prostate cancer; and TLX101, which is in Phase I/II clinical trial for the treatment of glioblastoma (brain cancer). The company has a development collaboration agreement with ARTMS Products Inc. for the manufacture of its prostate cancer imaging product TLX591-CDx (68Ga-PSMA-11 injection) for the imaging of prostate cancer with Positron Emission Tomography (PET). Telix Pharmaceuticals Limited was founded in 2015 and is headquartered in North Melbourne, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.142857,"avgChangeRate":-0.055106},{"month":2,"riseRate":0.571429,"avgChangeRate":-0.00178},{"month":3,"riseRate":0.857143,"avgChangeRate":0.161224},{"month":4,"riseRate":0.857143,"avgChangeRate":0.101504},{"month":5,"riseRate":0.333333,"avgChangeRate":0.060282},{"month":6,"riseRate":0.666667,"avgChangeRate":0.111666},{"month":7,"riseRate":0.5,"avgChangeRate":0.104857},{"month":8,"riseRate":0.5,"avgChangeRate":-0.036531},{"month":9,"riseRate":0.666667,"avgChangeRate":0.05206},{"month":10,"riseRate":0.833333,"avgChangeRate":0.211878},{"month":11,"riseRate":0.285714,"avgChangeRate":0.007547},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.00088}],"exchange":"ASX","name":"TELIX PHARMACEUTICALS LTD","nameEN":"TELIX PHARMACEUTICALS LTD"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TELIX PHARMACEUTICALS LTD(TLX.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest TELIX PHARMACEUTICALS LTD(TLX.AU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"TELIX PHARMACEUTICALS LTD,TLX.AU,TELIX PHARMACEUTICALS LTD股票,TELIX PHARMACEUTICALS LTD股票老虎,TELIX PHARMACEUTICALS LTD股票老虎国际,TELIX PHARMACEUTICALS LTD行情,TELIX PHARMACEUTICALS LTD股票行情,TELIX PHARMACEUTICALS LTD股价,TELIX PHARMACEUTICALS LTD股市,TELIX PHARMACEUTICALS LTD股票价格,TELIX PHARMACEUTICALS LTD股票交易,TELIX PHARMACEUTICALS LTD股票购买,TELIX PHARMACEUTICALS LTD股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TELIX PHARMACEUTICALS LTD(TLX.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest TELIX PHARMACEUTICALS LTD(TLX.AU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction